ReviewMolecular metabolism2021
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
762 papers cite itlatest 60 shown
this paperpooled ittrialcites it